The Effects of Sacroiliac Joint Manual Therapy on Autonomic Nervous System and Lower Abdominal Pain in Women in Their 20s With Primary Dysmenorrhea

December 24, 2023 updated by: Hyun-Joong Kim, Sahmyook University

Disorders of the autonomic nervous system are considered another possible cause of dysmenorrhea. spinal manual threapty is acting on the parasympathetic and sympathetic nerves.

The sacrum affects all vertebrae, which affects the position of this bone, is thought to have a lot to do with dysmenorrhea.

In this study, by applying spinal manual threapty threapty to the sacroiliac joint in women in their 20s with primary dysmenorrhea, we tried to present an effective treatment method by evaluating the function of the autonomic nervous system and confirming the occurrence of pain in the lower abdomen.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 29 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Women between the ages of 20-29
  • Regular menstrual cycle (24-32 days)
  • Those who have had symptoms of primary dysmenorrhea for at least 1 year
  • Those who have lower back pain symptoms related to menstrual pain of 5 or higher on the Visual Analysis Scale (VAS)
  • The body mass index is between 20-30
  • Positive reaction to Gillet test

Exclusion Criteria:

  • pelvic inflammatory disease
  • uterine fibroids, polycystic ovary syndrome. Those with gynecological findings such as endometriosis
  • Those who have used an intrauterine contraceptive device
  • Those who took birth control pills or nonsteroidal anti-inflammatory drugs at the time of the experiment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: spine manual therapy of sacroiliac joint
The group which treats spine manual therapy of sacroiliac joint
The manual treatment method applied to the sacroiliac joint used high-velocity, low amplitude (HVLA).
Active Comparator: Superficial heat therapy
Group treated with superficial heat therapy for 20 minutes
In the physical therapy used in this study, it was applied for 20 minutes using conventionally used superficial heat therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate Variability
Time Frame: Change from baseline after intervention at 4 weeks, follow-up at 4 weeks
Autonomic nervous system balance tester (SA3000new, Medicore Co. Korea) was used. The subjects placed electrodes on three areas (left arm, left leg, right leg) while lying down and performed for 3 minutes.
Change from baseline after intervention at 4 weeks, follow-up at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale
Time Frame: Change from baseline after intervention at 4 weeks, follow-up at 4 weeks
On a line consisting of 10 cm, 0 at either end represents 'no pain' and 10 represents 'worst pain'.
Change from baseline after intervention at 4 weeks, follow-up at 4 weeks
Pressure pain threshold
Time Frame: Change from baseline after intervention at 4 weeks, follow-up at 4 weeks

The test determines the amount of pressure over a given area in which a steadily increasing nonpainful pressure stimulus turns into a painful pressure sensation. With the participant seated comfortably, the examiner identified the sacroiliac joint and applied pressure with the algometer perpendicular to the skin surface until the participant made an "Ah" sound.

  • Lower pressure pain thresholds indicate higher sensitivity to pressure and a lower pain tolerance.
  • Higher pressure pain thresholds suggest lower sensitivity and a higher pain tolerance.
Change from baseline after intervention at 4 weeks, follow-up at 4 weeks
Menstrual distress questionnaire
Time Frame: Change from baseline after intervention at 4 weeks, follow-up at 4 weeks

The Menstrual Distress Questionnaire (MDQ) is a standard method for measuring cyclical menstrual cycle symptoms. The MDQ can differentiate between cyclical and non-cyclical changes in somatic symptoms, mood and behavior, and arousal.

-The measured scores range from 0 to 185; higher scores indicate severe dysmenorrhea symptoms.

Change from baseline after intervention at 4 weeks, follow-up at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sungeon Park, Ph.D candidate, The wells neuropain clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2023

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

August 30, 2023

Study Registration Dates

First Submitted

February 21, 2023

First Submitted That Met QC Criteria

February 21, 2023

First Posted (Actual)

March 3, 2023

Study Record Updates

Last Update Posted (Estimated)

December 27, 2023

Last Update Submitted That Met QC Criteria

December 24, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Dysmenorrhea

Clinical Trials on spine manual therapy

Subscribe